Rigel Pharmaceuticals, Inc.【RIGL】 減価償却費の推移

機能の使い方
(単位:ドル) 減価償却費 前年比(%)
4Q25 601,000 -0.5%
3Q25 603,000 -1.3%
2Q25 607,000 -1.0%
1Q25 604,000 +51.0%
4Q24 604,000 +106.1%
3Q24 611,000 +109.2%
2Q24 613,000 +107.1%
1Q24 400,000 +12.0%
4Q23 293,000 +3.2%
3Q23 292,000 +21.7%
2Q23 296,000 +24.9%
1Q23 357,000 +50.6%
4Q22 284,000 -35.7%
3Q22 240,000 -8.0%
2Q22 237,000 -8.1%
1Q22 237,000 -0.8%
4Q21 442,000 +114.6%
3Q21 261,000 +58.2%
2Q21 258,000 +57.3%
1Q21 239,000 +39.8%
4Q20 206,000 +14.4%
3Q20 165,000 -0.6%
2Q20 164,000 -5.2%
1Q20 171,000 +4.3%
4Q19 180,000 +10.4%
3Q19 166,000 +4.4%
2Q19 173,000 +8.8%
1Q19 164,000 +45.1%
4Q18 163,000 +44.2%
3Q18 159,000 +42.0%
2Q18 159,000 +39.5%
1Q18 113,000 -10.3%
4Q17 113,000 -21.0%
3Q17 112,000 -47.7%
2Q17 114,000 -56.2%
1Q17 126,000 -61.1%
4Q16 143,000 -57.7%
3Q16 214,000 -25.4%
2Q16 260,000 -31.4%
1Q16 324,000 -25.5%
4Q15 338,000 -33.3%
3Q15 287,000 -50.0%
2Q15 379,000 -39.2%
1Q15 435,000 -33.6%
4Q14 507,000 -22.1%
3Q14 574,000 -10.9%
2Q14 623,000 -0.8%
1Q14 655,000 -2.1%
4Q13 651,000 +2.4%
3Q13 644,000 +1.4%
2Q13 628,000 +3.0%
1Q13 669,000 +21.2%
4Q12 636,000 +20.9%
3Q12 635,000 +25.5%
2Q12 610,000 -
1Q12 552,000 -
4Q11 526,000 -
3Q11 506,000 -